Skip to main content
Fig. 3 | BMC Cancer

Fig. 3

From: Rituximab plus chemotherapy as first-line treatment in Chinese patients with diffuse large B-cell lymphoma in routine practice: a prospective, multicentre, non-interventional study

Fig. 3

Treatment effectiveness of R-chemo in patients with HBV infectious status (Patients who received ≥1 dose of R-chemo and underwent ≥1 tumor assessment after baseline were included in the analysis chemo, chemotherapy; CR, complete response; CRu, complete response unconfirmed; PR, partial response; ORR, overall response rate; R, rituximab)

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us